RNXT - RenovoRx, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.13 0.19 (16.81%)	0.0 (0.0%)	0.02 (1.54%)	0.03 (2.33%)	-0.05 (-4.42%)	0.19 (17.12%)	0.03 (2.33%)	0.03 (2.33%)

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.08
Diluted EPS:: -0.08
Basic P/E:: -16.5
Diluted P/E:: -16.5
RSI(14) 1m:: 100.0
VWAP:: 1.32
RVol:: 1.1212

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.29 +0.02 (+1.57%)	Oct 15 16:36
10m	Price increase 10m	1.3 +0.04 (+3.26%)	Oct 15 15:59
1m	Price increase 1m	1.3 +0.02 (+1.56%)	Oct 15 15:59
1m	Price increase 1m	1.28 +0.01 (+1.1%)	Oct 15 15:54
60m	Price increase 60m	1.26 +0.06 (+5.37%)	Oct 15 15:50